Legal Notice

 

Researchers Database

You have entered the IISP: Interactive Information System on Pathogenomics

 

If you would like to insert information about your research or research group, please click to the following link to download the form. After filling it out, please send back to m.karrasch@fz-juelich.de or g.gebreselassie@fz-juelich.de.

Here you will find information about Research groups in the PathoGenoMics fields from the ERA-NET partner countries (Austria, Finland, France, Hungary, Israel, Latvia, Portugal, Slovenia and Spain).
This information is supposed to support cooperation between researchers from different European countries
and thus enhance the development of a European Research Area for PathoGenoMics .

 

The following information is available and can be searched for:

  • researcher names
  • Institution of the respective researcher, city and country of his/her institution
  • Contact data of the researcher (address, phone, email)
  • Research topics and studied microorganisms of the researcher
  • Special techniques applied by the researcher
  • Potential cooperation topics suggested by the researcher

If you have any comments/questions or if you would like to add some information, please contact m.karrasch@fz-juelich.de

back to list

   
Name: Dr. Mutabilis Escaich, Sonia
Address:
Institution:
 
City: Zip:
Country: France Phone:
    Fax:
Email:
www: http://www.mutabilis.fr

 

Research Topics:
Antibacterial, antivirulence, drug discovery, innate immunity Mutabilis is a biopharmaceutical company specializing in antibacterial drug discovery. The company’s focus is to create a new class of anti-infectious drugs by developing molecules with new mechanisms of action. A new antibacterial concept called antivirulence is used to discover new drugs that selectively aim at pathogenic bacteria as soon as they spread via the bloodstream or extra cellular fluids, without preventing the proliferation of bacteria of the normal flora. Our research focus on findingnew antibacterial drugs active against resistant strains and new therapies for hospital-acquired infections. To this end research are directed to the identification of new bacterial targets in particular targets involved in the response to innate immunity

 

Organisms studied:
  • Staphylococcus
  • Streptococci

 

Special methods / technologies:
• Methods for the identification of highly conserved genes of major pathogenic species that are essential for establishment of infections (Mutagenesis, genomics analysis and biochemical validation of targets for inhibition) • Screening assays development and medicinal chemistry and drug discovery programs based on rational approaches against Gram- and Gram virulence targets;

 

Suggestions for potential research cooperations:
 
   
   
   
     
Optimized for Internet Explorer version 5.0 or higher
Last update on 23.03.2012 Webmaster
URL: https://www.pathogenomics-era.net